These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33771405)

  • 21. Spirituality and associated factors among cancer patients undergoing chemotherapy.
    Kamijo Y; Miyamura T
    Jpn J Nurs Sci; 2020 Jan; 17(1):e12276. PubMed ID: 31613426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials.
    Maringwa JT; Quinten C; King M; Ringash J; Osoba D; Coens C; Martinelli F; Vercauteren J; Cleeland CS; Flechtner H; Gotay C; Greimel E; Taphoorn MJ; Reeve BB; Koch JS; Weis J; Smit EF; van Meerbeeck JP; Bottomley A;
    Support Care Cancer; 2011 Nov; 19(11):1753-60. PubMed ID: 20886240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trait mindfulness and depressive symptoms in non-small cell lung cancer patients: the mediating roles of quality of life and meaning in life.
    Hsieh CC; Ho CC; Lin ZZ; Yu CJ; Jow GM; Huang FY; Shih JY; Hsiao FH
    Psychol Health; 2021 Sep; 36(9):1102-1114. PubMed ID: 32998574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Palliative care and spiritual well-being in lung cancer patients and family caregivers.
    Sun V; Kim JY; Irish TL; Borneman T; Sidhu RK; Klein L; Ferrell B
    Psychooncology; 2016 Dec; 25(12):1448-1455. PubMed ID: 26374624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between the magnitude of symptoms and the quality of life: a cluster analysis of lung cancer patients in Brazil.
    Franceschini J; Jardim JR; Fernandes AL; Jamnik S; Santoro IL
    J Bras Pneumol; 2013; 39(1):23-31. PubMed ID: 23503482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life in patients with advanced non-small cell lung cancer.
    Bozcuk H; Dalmis B; Samur M; Ozdogan M; Artac M; Savas B
    Cancer Nurs; 2006; 29(2):104-10. PubMed ID: 16565619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
    Koller M; Shamieh O; Hjermstad MJ; Hornslien K; Young T; Chalk T; Ioannidis G; Harle A; Johnson CD; Tomaszewski KA; Serpentini S; Pinto M; van der Weijst L; Janssens A; Morag O; Chie WC; Arraras JI; Pompili C; Jungraithmayr W; Hechtner M; Katsochi D; Müller K; Gräfenstein L; Schulz C; Bottomley A; ; ;
    Lancet Oncol; 2020 May; 21(5):723-732. PubMed ID: 32213338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.
    Paccagnella A; Favaretto A; Oniga F; Barbieri F; Ceresoli G; Torri W; Villa E; Verusio C; Cetto GL; Santo A; De Pangher V; Artioli F; Cacciani GC; Parodi G; Soresi F; Ghi MG; Morabito A; Biason R; Giusto M; Mosconi P; Chiarion Sileni V;
    Lung Cancer; 2004 Jan; 43(1):83-91. PubMed ID: 14698542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of life results from a randomized, double-blinded, placebo-controlled, multi-center phase III trial of anlotinib in patients with advanced non-small cell lung cancer.
    Si X; Zhang L; Wang H; Zhang X; Wang M; Han B; Li K; Wang Q; Shi J; Wang Z; Cheng Y; He J; Shi Y; Chen W; Wang X; Luo Y; Nan K; Jin F; Li B; Chen Y; Zhou J; Wang D
    Lung Cancer; 2018 Aug; 122():32-37. PubMed ID: 30032842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III study.
    Goldman JW; Garassino MC; Chen Y; Özgüroğlu M; Dvorkin M; Trukhin D; Statsenko G; Hotta K; Ji JH; Hochmair MJ; Voitko O; Havel L; Poltoratskiy A; Losonczy G; Reinmuth N; Patel N; Laud PJ; Shire N; Jiang H; Paz-Ares L
    Lung Cancer; 2020 Nov; 149():46-52. PubMed ID: 32961445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment quality of life of inoperable non-small cell lung cancer patients referred for primary radiotherapy.
    Langendijk JA; Aaronson NK; ten Velde GP; de Jong JM; Muller MJ; Wouters EF
    Acta Oncol; 2000; 39(8):949-58. PubMed ID: 11207002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of life after curative radiotherapy in Stage I non-small-cell lung cancer.
    Langendijk JA; Aaronson NK; de Jong JM; ten Velde GP; Muller MJ; Slotman BJ; Wouters EF
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):847-53. PubMed ID: 12095549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21.
    Bezjak A; Tu D; Seymour L; Clark G; Trajkovic A; Zukin M; Ayoub J; Lago S; de Albuquerque Ribeiro R; Gerogianni A; Cyjon A; Noble J; Laberge F; Chan RT; Fenton D; von Pawel J; Reck M; Shepherd FA;
    J Clin Oncol; 2006 Aug; 24(24):3831-7. PubMed ID: 16921034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of depressive symptoms, personality traits, and sociodemographic factors with health-related quality of life and quality of life in patients with advanced-stage lung cancer: an observational multi-center cohort study.
    de Mol M; Visser S; Aerts J; Lodder P; van Walree N; Belderbos H; den Oudsten B
    BMC Cancer; 2020 May; 20(1):431. PubMed ID: 32423432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Symptom clusters during palliative chemotherapy and their influence on functioning and quality of life.
    Rha SY; Lee J
    Support Care Cancer; 2017 May; 25(5):1519-1527. PubMed ID: 28032218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
    Hui R; Özgüroğlu M; Villegas A; Daniel D; Vicente D; Murakami S; Yokoi T; Chiappori A; Lee KH; de Wit M; Cho BC; Gray JE; Rydén A; Viviers L; Poole L; Zhang Y; Dennis PA; Antonia SJ
    Lancet Oncol; 2019 Dec; 20(12):1670-1680. PubMed ID: 31601496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.
    Kemmler G; Holzner B; Kopp M; Dünser M; Margreiter R; Greil R; Sperner-Unterweger B
    J Clin Oncol; 1999 Sep; 17(9):2932-40. PubMed ID: 10561373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Undernutrition and quality of life in non small cell lung cancer patients].
    Xará S; Amaral TF; Parente B
    Rev Port Pneumol; 2011; 17(4):153-8. PubMed ID: 21664101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A path analysis model of spiritual well-being and quality of life in Iranian cancer patients: a mediating role of hope.
    Sharif Nia H; Lehto RH; Seyedfatemi N; Mohammadinezhad M
    Support Care Cancer; 2021 Oct; 29(10):6013-6019. PubMed ID: 33782763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. All's well that ends well? Quality of life and physical symptom clusters in long-term cancer survivors across cancer types.
    Zucca AC; Boyes AW; Linden W; Girgis A
    J Pain Symptom Manage; 2012 Apr; 43(4):720-31. PubMed ID: 22277904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.